Characterization of ERBB2 (HER2) Alterations in Metastatic Non-small Cell Lung Cancer and Comparison of Outcomes of Different Trastuzumab-based Regimens

Waliany, S; Wakelee, H; Ramchandran, K; Das, M; Huang, J; Myall, N; Li, CN; Pagtama, J; Tisch, AH; Neal, JW

Neal, JW (通讯作者),Stanford Univ, Div Oncol, Sch Med, 875 Blake Wilbur Dr, Palo Alto, CA 94304 USA.

CLINICAL LUNG CANCER, 2022; 23 (6): 498

Abstract

The association between specific ERBB2 mutations and outcomes with trastuzumab-based regimens in metastatic non-small cell lung cancer (mNSCLC) is spa......

Full Text Link